维普中文期刊产品整合服务
59篇 您的检索式:作者名="NAUCK T"
    题名 作者 年代 出处 被引量
1Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study 显示文摘Seck T Nauck M Sheng D 2010Int J Clin Pract2010,64,5:1
2Exenatide once weekly versus lira- glutide once daily in patients with type 2 diabetes (DURATION-6) : a randomised, open-label study显示文摘Buse J B Nauck M Forst T 2013Lancet2013,381,9861:1
3Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycae mic control with metformin: a 26 - week, randomised, parallel group ,open - label trial显示文摘Pratley RE Nauck M Bailey T 2010Lancet2010,375,:1
4Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin : a 2 - year study 显示文摘Seck T Nauck M Sheng D 2010Int J Clin Pract2010,64,:1
5Immunosuppression enhances atherogenicity of lipid profile after transplantation显示文摘Quaschning T Mainka T Nauck M 1999Kidney Int1999,71,7:1
6Periosteal repair of the dorsal calcaneocuboid ligament: a comparative biomechanical study 显示文摘Lohrer H Nauck T Dom-Lange NV 2007Foot Ankle Int2007,28,2:1
7Exenatide once weekly versusliraglutide once daily in patients with type 2 diabetes ( DURA-TION-6) :a randomised, open-label study 显示文摘Buse JB Nauck M Forst T 2013Lancet2013,381,9861:1
8Association between type 1 and type 2 diabetes with periodontal disease and tooth loss显示文摘Kaur G Holtfreter B Rathmann W Schwahn C Wallaschofski H Schipf S Nauck M Kocher T 0,,:1
9Safety and efficacy oftreatment with sitagliptin or glipizide in patients with type 2 dia-betes inadequately controlled on metformin : A 2-year study 显示文摘SECK T NAUCK M SHENG D 2010Int J Clin Pract y2010,64,5:1
10Incretin-based therapies:viewpoints on the way to consensus 2显示文摘Nauck MA Vilsboll T Gallwitz B 0,,2:1
11Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with mefformin:a 26-week,randomised,parallel-group,open-label trial显示文摘Pratley RE Nauck M Bailey T 0,,:1
12Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes:a randomized,open-label trial显示文摘Pratley RE Nauck MA Bailey T 2012Diabetes Care2012,35,10:1
13Morphology of the dorsal and lateral calcaneocuboid ligaments显示文摘Dorn-Lange NV Nauck T Lohrer H 0,,:1
14Immunosuppression enhances at herogenicity of lipid profile after transplantation显示文摘Quaschning T Mainka T Nauck M 1999Kidney Int1999,56,71:1
15Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial显示文摘Pratley RE Nauck M Bailey T 2010Lancet2010,,9724:1
16Liraglutide versus sitaglip- tin for patients with type 2 diabetes who did not have adequate glycaemie control with metformin: a 26-week, randomised, paral- lel-group, open-label trial显示文摘Pratley RE Nauck M Bailey T 2010Lancet2010,,:1
17Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study 显示文摘Seck T Nauck M Sheng D 2010Int J Clin Pract2010,64,5:1
18Comparison of radial versus focused extracorporeal shock waves in plantar fasciitis using functional measures显示文摘Lohrer H Nauck T Dorn-Lange NV 2010Foot Ankle Int2010,31,1:1
19Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glyeaemie control with metformin : a 26-keek, randomised , parallel-group,open-label trial 显示文摘PRATLEY RE NAUCK M BAILEY T 2010Lancet2010,375,4:1
20Liraglutide versus sitagliplin for patients with type 2 diabetes who did not have adequate glyeaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial显示文摘Pratley RE Nauck M Bailey T 2010Lancet2010,375,9724:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费